564
Views
7
CrossRef citations to date
0
Altmetric
Review

Hepatitis B-related glomerulonephritis and optimization of treatment

ORCID Icon, , , &
Pages 113-125 | Received 16 Sep 2019, Accepted 15 Jan 2020, Published online: 23 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Liping Ai, Qing-Qing Liu, Yize Li, Yuanyuan Wang & Hong-Mei Zhang. (2023) The Role of HBx Protein in Diseases Beyond the Liver. Infection and Drug Resistance 16, pages 3225-3232.
Read now
Feng Yu, Guanglan Li, Wenke Hao & Wenxue Hu. (2021) Hepatitis B Virus-Related Glomerulonephritis with Positive and Negative Serum HBsAg: Different Clinicopathologic Characteristics of Two Clinical Subtypes. International Journal of General Medicine 14, pages 3069-3077.
Read now

Articles from other publishers (5)

Mona Boudabbous, Fatma Bouzid, Ikram Agrebi, Héla Gdoura, Lassad Chtourou, Manel Moalla, Leila Mnif, Ali Amouri, Khaoula Kammoun & N Tahri. (2023) Screening for renal impairment in viral hepatopathy B: it is time to begin. Future Science OA 9:9.
Crossref
Xiaoqian Yang, Yani Yu, Baoshuang Li, Yueqi Chen, Moxuan Feng, Yongzheng Hu & Wei Jiang. (2023) Bone marrow mesenchymal stem cell-derived exosomes protect podocytes from HBx-induced ferroptosis. PeerJ 11, pages e15314.
Crossref
Daniel G. Sausen, Oren Shechter, William Bietsch, Zhenzhen Shi, Samantha M. Miller, Elisa S. Gallo, Harel Dahari & Ronen Borenstein. (2022) Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. International Journal of Molecular Sciences 23:24, pages 15973.
Crossref
Mei-Juan Peng, Xiao-Qing Guo, Wei-Lu Zhang, Jing Chen, Wen Kang, Xiao-Fei Yang, Ying Guo & Ye Zhang. (2022) Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience. Frontiers in Microbiology 13.
Crossref
Lihua Tan, Yanbei Tu, Kai Wang, Bing Han, Hongquan Peng & Chengwei He. (2020) Exploring protective effect of Glycine tabacina aqueous extract against nephrotic syndrome by network pharmacology and experimental verification. Chinese Medicine 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.